Table 2. Effect of chCCL-1 on Survival... | American Society of Hematology

Table 2.

Effect of chCCL-1 on Survival in Mice Bearing Human Lymphoma

Experiment Tumor	Initiation of Therapy	Treatment	Mean DOD	Range

Michel (ALCL)	3 d	msIgG1	31	30-32
		Lym-2	38	31-60
Raji (Burkitt's)	3 d	msIgG1	39	28-45
		Anti-CD40	72	57-91^*
		Lym-2	72	37-91^*
RL (Diffuse large cell)	3 d	msIgG1	70	58-81
	3 d	Lym-2	98	75-220^*
Daudi (Burkitt's)	3 d	msIgG1	37	34-50
	3 d	chCLL-1	84	40-104^*

Experiment Tumor	Initiation of Therapy	Treatment	Mean DOD	Range

Michel (ALCL)	3 d	msIgG1	31	30-32
		Lym-2	38	31-60
Raji (Burkitt's)	3 d	msIgG1	39	28-45
		Anti-CD40	72	57-91^*
		Lym-2	72	37-91^*
RL (Diffuse large cell)	3 d	msIgG1	70	58-81
	3 d	Lym-2	98	75-220^*
Daudi (Burkitt's)	3 d	msIgG1	37	34-50
	3 d	chCLL-1	84	40-104^*

Mice were treated with 2 μg of Lym-2, anti-CD40, chCCL-1, or msIgG1 as described in the Materials and Methods.

Abbreviations: DOD, day of death; ALCL, anaplastic large-cell lymphoma.

P < .01.

P < .005.